Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S613479-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
S613479-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,001.90 |
Synonyms | SC-51089|SC 51089 (free base)|CHEMBL155358|146033-03-6|SC51089|8-Chloro-N'-(3-(pyridin-4-yl)propanoyl)dibenzo[b,f][1,4]oxazepine-10(11H)-carbohydrazide|GTPL1923|BDBM85600|DTXSID001019062|HY-108563A|NSC_132748|3-chloro-N'-(3-pyridin-4-ylpropanoyl)-6H-benzo |
---|---|
Specifications & Purity | Moligand™ |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of EP 1 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 3-chloro-N'-(3-pyridin-4-ylpropanoyl)-6H-benzo[b][1,5]benzoxazepine-5-carbohydrazide |
---|---|
INCHI | InChI=1S/C22H19ClN4O3/c23-17-6-7-20-18(13-17)27(14-16-3-1-2-4-19(16)30-20)22(29)26-25-21(28)8-5-15-9-11-24-12-10-15/h1-4,6-7,9-13H,5,8,14H2,(H,25,28)(H,26,29) |
InChi Key | XDJPQOUDGROSEU-UHFFFAOYSA-N |
Canonical SMILES | O=C(NNC(=O)N1Cc2ccccc2Oc2c1cc(Cl)cc2)CCc1ccncc1 |
Isomeric SMILES | C1C2=CC=CC=C2OC3=C(N1C(=O)NNC(=O)CCC4=CC=NC=C4)C=C(C=C3)Cl |
PubChem CID | 132749 |
PubChem CID | 132749 |
---|---|
ChEBI | CHEBI:360002 |
ChEMBL Ligand | CHEMBL155358 |
GPCRdb Ligand | SC-51089 |
Enter Lot Number to search for COA: